Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02900495 · ClinicalTrials.gov registry record · NA

Transcutaneous Electric Nerve Stimulation (TENS) for the Treatment of Nocturnal Enuresis in Children

A NA study of Nocturnal Enuresis and Bedwetting, sponsored by Northwell Health.

Completed
Registry status
NA
Development phase
147
Enrollment target
5
Study locations

NCT02900495 is a NA study of Nocturnal Enuresis and Bedwetting that has completed, run by Northwell Health. The registered enrollment target is 147 participants. The trial reports 5 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02900495, a NA study of Nocturnal Enuresis and Bedwetting, has completed, sponsored by Northwell Health.

COMPLETED
Registry status
NA
Development phase
147 participants
Enrollment target
5
Study locations

Study Summary

Children referred to the pediatric urology clinic for primary nocturnal enuresis will be screened for enrollment. Patients who fail behavioral therapy and who meet inclusion criteria will be offered therapy with a TENS unit. Patients will be randomized into four groups. Group 1 will be the direct bladder stimulation arm with electrodes placed onto the abdomen in the suprapubic region directly over the bladder. Group 2 will be the distal neural loop arm with electrodes placed over the posterior tibial nerve. Group 3 will be the proximal neural loop arm with electrodes placed about 2-3 cm lateral to the midline in the sacral region at the level of S3. Group 4 will be the control arm with electrodes placed on the scapula. We will aim to recruit 32 patients per group for a total of 128 patients. The patients will be provided with a TENS unit (TENS 3000 Analog) and electrode pads and caretakers instructed on how to use the apparatus. The TENS sessions will be performed nightly before bed for 15 minutes. TENS units will be set at a frequency of 10 Hz, and intensity determined by the sensitivity threshold of the patient. Diaries including nighttime incontinence episodes and a "wet sheet" scale (dry, damp, wet, soaked) will be recorded, along with any adverse reactions to the TENS unit. Patients will be followed up after one month of TENS with evaluation including the Pediatric Urinary Incontinence Questionnaire, a validated tool for measuring quality of life in children with bladder dysfunction; this questionnaire will be filled out prior to starting TENS treatment in order to compare the effect of treatment on QOL. . They will then follow up on these parameters again after another month (one month off of TENS therapy) to assess the durability of treatment effect. The data will be collected at different time points (baseline, 1 month, 2 months) for each group by itself and the groups compared against each other using statistical analysis.

Interventions

  • DEVICE transcutaneous electric nerve stimulation

Study Locations (5)

New York

  • Albany Medical College - Albany
  • Pediatric Urology Associates - Brooklyn
  • Cohen Children's Medical Center of NY - New Hyde Park
  • Pediatric Urology Associates - New Hyde Park
  • Pediatric Urology Associates - Tarrytown

Trial Details

FieldValue
Enrollment Target 147 participants
Start Date 2016-08
Est. Completion 2020-09-15
Phase NA

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT02900495

The ClinicalTrials.gov registry entry for NCT02900495 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 147 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Nocturnal Enuresis appearing as the primary indexed condition, and to 1 intervention - of which transcutaneous electric nerve stimulation is the first listed.

NCT02900495 reports 5 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02900495 about?

NCT02900495 is a clinical study titled "Transcutaneous Electric Nerve Stimulation (TENS) for the Treatment of Nocturnal Enuresis in Children". Children referred to the pediatric urology clinic for primary nocturnal enuresis will be screened for enrollment. Patients who fail behavioral therapy and who meet inclusion criteria will be offered therapy with a TENS unit. Patients will be randomized into four groups. Group 1 will be the direct b...

What is the current status of trial NCT02900495?

This trial is currently completed. It is a NA study. The enrollment target is 147 participants. The study started on 2016-08. Estimated completion is 2020-09-15.

What conditions does trial NCT02900495 study?

This clinical trial studies the following conditions: Nocturnal Enuresis, Bedwetting.

What interventions are being tested in trial NCT02900495?

The interventions under investigation include: transcutaneous electric nerve stimulation (DEVICE).

Who is sponsoring clinical trial NCT02900495?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02900495 being conducted?

This trial has 5 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nocturnal Enuresis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.